Results 11 to 20 of about 355,432 (267)

The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination

open access: yesHeliyon, 2016
Since 2010, Denmark has included the 13-valent pneumococcal conjugated vaccine (PCV-13) in the childhood immunization programme. However, serotype 3 remains as an important cause of invasive pneumococcal disease (IPD) in Denmark.
Hans-Christian Slotved   +7 more
doaj   +1 more source

Glomerulonefritis proliferativa extracapilar como espectro clínico inusual en un paciente con glomerulonefritis posestreptocócica

open access: yesRevista Colombiana de Nefrología, 2021
La glomerulonefritis post-infecciosa puede ser desencadenada por virus, bacterias hongos o parásitos. Estos agentes pueden desencadenar  una respuesta inflamatoria no controlada sobre el glomérulo y túbulo renal, donde participan la formación de ...
Omar Cabarcas Barbosa   +4 more
doaj   +1 more source

Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus

open access: yesJournal of Immunology Research, 2015
Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and invasive diseases.
Shu Ki Tsoi   +4 more
doaj   +1 more source

Streptococcal group B integrative and mobilizable element IMESag-rpsI encodes a functional relaxase involved in its transfer [PDF]

open access: yesOpen Biology, 2016
Streptococcus agalactiae or Group B Streptococcus (GBS) are opportunistic bacteria that can cause lethal sepsis in children and immuno-compromised patients.
Fabian Lorenzo-Diaz   +6 more
doaj   +1 more source

IMMUNOGENICITY OF THE EXPERIMENTAL ASSOCIATED VACCINE AGAINST MASTITIS IN COWS

open access: yesВетеринарная патология, 2022
Currently, mastitis of infectious etiology remains a significant problem for dairy farming, which are widespread and cause enormous economic damage. The frequency of occurrence of mastitis by months during the year varies from 1.9 to 7.7 %.
E. V. Remizova   +7 more
doaj   +1 more source

Streptococcus pseudopneumoniae [PDF]

open access: yesRevista chilena de infectología, 2010
Nueva especie bacteriana, descrita por primera vez el año 2004 por Arbique y cols. Estudios de homología de ADN-ADN sugieren que corresponde a una especie distinta de Streptococcus pneumoniae y Streptococcus mitis. Esta nueva especie muestra una similitud cercana a 50% con S. pneumoniae.
openaire   +3 more sources

Ceftaroline activity on certain respiratory tract and wound infection agents at the minimum inhibitory concentration level

open access: yesJournal of Infection in Developing Countries, 2015
Introduction: The aim of this study was to investigate the effectiveness of ceftaroline against agents frequently isolated from respiratory tract and wound infections. Methodology: The study included a total of 250 strains isolated from various clinical
Keramettin Yanik   +6 more
doaj   +1 more source

Group A streptococcus [PDF]

open access: yesCanadian Medical Association Journal, 2015
It was gratifying to read that the authors of this commentary[1][1] on group A streptococcus mention the significant rate of colonization versus infection. Surprisingly, this was not mentioned in the related research article.[2][2] This continuing uncertainty, so appropriate in science ...
openaire   +2 more sources

Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group" [PDF]

open access: yesJournal of Clinical Microbiology, 1990
A biochemical scheme was developed by which strains of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus can reliably be distinguished from within the "Streptococcus milleri group." Strains identified as S. intermedius were differentiated by the ability to produce detectable levels of alpha-glucosidase, beta ...
R A, Whiley   +3 more
openaire   +2 more sources

A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A

open access: yesVaccines, 2015
Alternatives to the well-established capsular polysaccharide-based vaccines against Streptococcus pneumoniae that circumvent limitations arising from limited serotype coverage and the emergence of resistance due to capsule switching (serotype replacement)
Marco Tamborrini   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy